Clinical Trial Update: TReatment for ImmUne Mediated PathopHysiology [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases is recruiting to treat immune-mediated pathophysiolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fulminant Hepatic Failure
• Hepatic Encephalopathy
• Liver Failure
• Liver Injury

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Acute Liver Failure, Fulminant Hepatic Failure | Phase 2 | Status: RECRUITING